Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation in Breast Tumors in Early Stages

NCT04389216 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT04389216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation in Breast Tumors in Early Stages
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2020
Completion date
September 9, 2025
Enrollment
30 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female